Pcn59 - Association Between Hazard Ratios of Surrogate Time-To-Event Endpoints and Overall Survival in Advanced/Metastatic Cancers

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.141
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Tumor Response and Progression-Free Survival as Potential Surrogate Endpoints for Overall Survival in Extensive Stage Small-Cell Lung Cancer

Cancer
Cancer ResearchOncology
2010English

Surrogate Endpoints in Advanced Sarcoma Trials: A Meta-Analysis

Oncotarget
Oncology
2018English

Prm1 - Validation of Alternative “Surrogate” Clinical Endpoints in Advanced Melanoma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

HER3 Over-Expression and Overall Survival in Gastrointestinal Cancers

Oncotarget
Oncology
2015English

Validation of Surrogate End Points for Overall Survival in Advanced Colorectal Cancer: A Harmonized Approach Is Needed

Journal of Clinical Epidemiology
Epidemiology
2016English

Association Between Early Nutritional Risk and Overall Survival in Patients With Advanced Pancreatic Cancer: A Single-Center Retrospective Study

Clinical Nutrition ESPEN
EndocrinologyNutritionMetabolismDieteticsDiabetes
2019English

Mp76-09 Predictors of Metastasis at Time of Diagnosis and Overall Survival in Metastatic Testicular Cancer

Journal of Urology
Urology
2017English

Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2017English

Association of Optimal Time Interval to Re-Resection for Incidental Gallbladder Cancer With Overall Survival

JAMA Surgery
Surgery
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy